SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as traders closely monitor rising geopolitical tensions in the Middle East following reports of new military strikes and disruptions in the Strait of Hormuz. Market participants are actively debating the potential for increased volatility and its impact on the tech sector, balancing concerns over global supply chain stability against expectations for upcoming earnings reports.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is facing heightened volatility and selling pressure as the market reacts to a significant escalation in the US-Iran conflict, with intensified military actions around the Strait of Hormuz. While some investors are bracing for a deeper correction and potential supply chain disruptions, the community remains divided between those expecting a continued bearish downturn and those banking on a swift reversal driven by historical patterns of market manipulation and intervention.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors navigate aggressive rebalancing by Korea's National Pension Service and significant fluctuations in semiconductor demand. Community sentiment remains polarized, with many traders focused on leveraging the upcoming US listing of SK Hynix and the stock's impending 20-for-1 split as potential catalysts for a recovery.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is trending following its major US market debut, with the community actively debating whether the high valuation and arbitrage potential justify a buy or signal an impending sell-the-news event. Investors are closely monitoring its performance relative to established memory players like Micron, as discussions focus on the company's HBM market leadership and the broader impact of AI-driven memory demand.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is surging as investors cheer the launch of its Muse Spark AI model and reports that the company is slashing AI infrastructure costs through efficient custom chip production. The community is actively debating whether this aggressive AI expansion represents a durable long-term advantage or a high-risk gamble on capital expenditure that could face regulatory hurdles.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently a central focus for investors navigating the AI energy bottleneck, with ongoing community debate centered on institutional growth catalysts like the expanded partnership with Brookfield. The stock has experienced significant volatility as participants weigh long-term demand for fuel cell-powered data centers against recent short-seller allegations regarding supply chain sourcing and project backlog transparency.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently drawing intense community focus due to speculation surrounding a potential shift toward large-scale Optimus humanoid robot production and ongoing debates over its autonomous driving timeline. Investors are actively tracking technical support levels and high-volume options activity as they weigh the company's valuation against institutional skepticism regarding competitive pressures and manufacturing timelines.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

The RAM ETF, a 2x leveraged vehicle tracking the DRAM index, is facing extreme volatility as investors debate whether semiconductor momentum is stalling or if current pullbacks are merely temporary noise in a long-term AI memory supercycle. Community sentiment remains sharply divided, with some traders aggressively buying dips in anticipation of future earnings beats, while others warn of significant downside risk due to the fund's aggressive leverage and broader sector cooling.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users grapple with the sudden death of Senator Lindsey Graham, fueling intense speculation and partisan conflict regarding the administration's health and foreign policy moves. The stock remains a focal point for heated discussions surrounding ongoing regional tensions in the Middle East and the broader political landscape as the community reacts to these volatile developments.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Investors are actively debating the viability of UVXY as a hedge, with many community members frustrated by its structural decay and alleging market manipulation amidst geopolitical tensions in the Middle East. Discussion remains polarized, as some traders look for a major volatility spike due to war concerns and potential bubble risks, while others dismiss the asset as a perpetual trap that consistently underperforms against S&P 500 rallies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire NEW YORK, July 9, 2026 NEW YORK, July 9, 2026 /PRNewswire...

Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?

CRINETICS PHARM (CRNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ARS Pharmaceuticals (SPRY) Securities Fraud Investigation - Levi & Korsinsky

ARS Pharmaceuticals (SPRY) Securities Fraud Investigation - Levi & Korsinsky ARS Pharmaceuticals (SPRY) Securities Fraud Investigation - Levi & Korsinsky PR Newswire NEW YORK, July 6, 2026 ARS Pharmaceuticals stock lost more than 23% of its value in a single after-hours session after Neffy failed...

SPRY Investor Alert: Levi & Korsinsky Investigates ARS Pharmaceuticals (SPRY) for Potential Securities Fraud

Shareholders who held ARS Pharmaceuticals (NASDAQ: SPRY) stock watched the value drop more than 23% in after-hours trading on June 24, 2026, after the Company disclosed that Neffy received no new commercial formulary additions or payer-coverage decisions in the July 1, 2026 review cycle. Investors...

ARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals (SPRY)

ARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals (SPRY) ARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals (SPRY) PR Newswire NEW YORK, June 29, 2026...

SPRY Investors Have Opportunity to Join ARS Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (ARS or the Company) (NASDAQ: SPRY) for violations of the securities laws.The investigation focuses on whether the Company issued false...

SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today

Equity

The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans. 


SPRY Stock Tanks Over 23% After-Hours — ARS Pharmaceuticals Reports No New Major Insurance Wins For Neffy 

Many patients will continue to face higher out-of-pocket costs or rely on the company’s cash-pay option without broader commercial coverage.


ARS Pharmaceuticals Q1 Earnings Call Highlights

ARS Pharmaceuticals Q1 Earnings Call Highlights...

ARS Pharmaceuticals Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.48	--	--	N/A
Q1 '26	-$0.52	-$0.61	-18.22%	MISSED
Q4 '25	-$0.43	-$0.41	4.62%	BEAT
Q3 '25	-$0.45	-$0.52	-14.59%	MISSED
Q2 '25	-$0.46	-$0.46	-0.43%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

SPRYARS Pharmaceuticals Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SPRY News